Pharmaceutical companies—including Eli Lilly and Novo Nordisk, which currently dominate the obesity market—have been testing ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Most U.S. stocks rose, but the worst drop for UnitedHealth Group in a quarter century kept Wall Street in check.

U.S. stocks ended mixed Thursday, with the Dow losing ground as sharp moves lower in healthcare stocks shaped a volatile ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Eli Lilly said its experimental drug, orforglipron, helped people with Type 2 diabetes lower their blood sugar and lose weight. The company is hoping to bring the first GLP-1 weight-loss pill to ...

Most U.S. stocks climbed Thursday, but the worst drop for UnitedHealth Group in a quarter of a century kept Wall Street in ...

If approved, the pill is expected to be far easier to administer than current injectables — and far easier to manufacture.

The drug helped lower patients’ blood sugar and reduce their weight by an average of 16 pounds.

We recently published a list of the 10 Best Long Term Stocks to Buy According to Billionaires. In this article, we are going ...